137 related articles for article (PubMed ID: 33484974)
1. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract][Full Text] [Related]
2. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
3. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
[TBL] [Abstract][Full Text] [Related]
4. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.
van Putten M; Verhoeven RH; van Sandick JW; Plukker JT; Lemmens VE; Wijnhoven BP; Nieuwenhuijzen GA
Br J Surg; 2016 Feb; 103(3):233-41. PubMed ID: 26621158
[TBL] [Abstract][Full Text] [Related]
5. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
[TBL] [Abstract][Full Text] [Related]
6. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Wijnhoven BP; Nieuwenhuijzen GA
Eur J Surg Oncol; 2014 Oct; 40(10):1338-45. PubMed ID: 24484779
[TBL] [Abstract][Full Text] [Related]
7. Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.
Luijten JCHBM; Vissers PAJ; Brom L; de Bièvre M; Buijsen J; Rozema T; Mohammad NH; van Duijvendijk P; Kouwenhoven EA; Eshuis WJ; Rosman C; Siersema PD; van Laarhoven HWM; Verhoeven RHA; Nieuwenhuijzen GAP; Westerman MJ
BMC Health Serv Res; 2022 Apr; 22(1):527. PubMed ID: 35449018
[TBL] [Abstract][Full Text] [Related]
8. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
[TBL] [Abstract][Full Text] [Related]
9. Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival.
van Hoeve JC; Verhoeven RHA; Nagengast WB; Oppedijk V; Lynch MG; van Rooijen JM; Veldhuis P; Siesling S; Kouwenhoven EA
Eur J Surg Oncol; 2023 Jan; 49(1):106-112. PubMed ID: 35963750
[TBL] [Abstract][Full Text] [Related]
10. Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
Luijten JCHBM; Vissers PAJ; Geerts J; Lemmens VEP; van Hillegersberg R; Beerepoot L; Walraven JEW; Curvers W; Voncken FEM; van der Sangen M; Verhoeven RHA; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2023 Sep; 49(9):106880. PubMed ID: 37055281
[TBL] [Abstract][Full Text] [Related]
11. The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
Vissers PAJ; Luijten JCHBM; Lemmens VEPP; van Laarhoven HWM; Slingerland M; Wijnhoven BPL; Rosman C; Mook S; Heisterkamp J; Hendriksen EM; Gisbertz SS; Nieuwenhuijzen GAP; Verhoeven RHA
Eur J Surg Oncol; 2023 Oct; 49(10):107019. PubMed ID: 37659340
[TBL] [Abstract][Full Text] [Related]
12. The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer.
Doeve BH; Bakx JAC; Siersema PD; Rosman C; van Grieken NCT; van Berge Henegouwen MI; van Sandick JW; Verheij M; Bijlsma MF; Verhoeven RHA; van Laarhoven HWM
J Gastroenterol; 2023 Oct; 58(10):965-977. PubMed ID: 37523094
[TBL] [Abstract][Full Text] [Related]
13. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.
Elferink MA; Krijnen P; Wouters MW; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Langendijk JA; Marijnen CA; Siesling S; Tollenaar RA
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S74-82. PubMed ID: 20598844
[TBL] [Abstract][Full Text] [Related]
14. Treatment decision-making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study.
Luijten JCHBM; Brom L; Vissers PAJ; van de Wouw YAJ; Warmerdam FARM; Heisterkamp J; Mook S; Oulad Hadj J; van Det MJ; Timmermans L; Hulshof MCCM; van Laarhoven HWM; Rosman C; Siersema PD; Westerman MJ; Verhoeven RHA; Nieuwenhuijzen GAP
Cancer Med; 2022 Jun; 11(12):2427-2444. PubMed ID: 35166037
[TBL] [Abstract][Full Text] [Related]
15. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
Opstelten JL; de Wijkerslooth LR; Leenders M; Bac DJ; Brink MA; Loffeld BC; Meijnen-Bult MJ; Minderhoud IM; Verhagen MA; van Oijen MG; Siersema PD
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26919349
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with esophageal and gastric cancer in Sri Lanka: A retrospective survival analysis.
Wijesekera S; Alagiyawanna L; Peiris V; Silva DC; Rupasinghe T; Balawardena J; Skandarajah T; Jeyakumaran N; Gunasekera D; Bandusena M; Joseph N
J Cancer Res Ther; 2023 Apr; 19(Supplement):S294-S299. PubMed ID: 37148006
[TBL] [Abstract][Full Text] [Related]
17. SOURCE: Prediction Models for Overall Survival in Patients With Metastatic and Potentially Curable Esophageal and Gastric Cancer.
van den Boorn HG; Abu-Hanna A; Haj Mohammad N; Hulshof MCCM; Gisbertz SS; Klarenbeek BR; Slingerland M; Beerepoot LV; Rozema T; Sprangers MAG; Verhoeven RHA; van Oijen MGH; Zwinderman KH; van Laarhoven HWM
J Natl Compr Canc Netw; 2021 Apr; 19(4):403-410. PubMed ID: 33636694
[TBL] [Abstract][Full Text] [Related]
18. Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery.
Timmermans M; Schuurman MS; Ho VKY; Massuger LF; Nijman HW; van Gorp T; Sonke GS; Kruitwagen RFPM; van der Aa MA
Gynecol Oncol; 2018 Jan; 148(1):56-61. PubMed ID: 29129391
[TBL] [Abstract][Full Text] [Related]
19. Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden.
Linder G; Sandin F; Johansson J; Lindblad M; Lundell L; Hedberg J
Cancer Epidemiol; 2018 Feb; 52():91-98. PubMed ID: 29278841
[TBL] [Abstract][Full Text] [Related]
20. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
Schouwenburg MG; Busweiler LAD; Beck N; Henneman D; Amodio S; van Berge Henegouwen MI; Cats A; van Hillegersberg R; van Sandick JW; Wijnhoven BPL; Wouters MWJ; Nieuwenhuijzen GAP;
Eur J Surg Oncol; 2018 Apr; 44(4):532-538. PubMed ID: 29439836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
